Search for: "Bayer Corp" Results 1 - 20 of 512
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Mar 2024, 12:46 pm by admin
Supp. 2d 977, 1001 (D.Minn. 2007) (holding expert witness to have exceeded proper proffer “to the extent that he speculates as to Bayer’s motive, intent, or state of mind”); 532 F. [read post]
16 Aug 2022, 8:00 am by Robert Kreisman
Related blog posts: Illinois Appellate Court Finds That Physician and Pharmacy Have No Duty to Warn of Medical Risks Associated With Long-Term Use of Reglan State Supreme Court Affirms Dismissal of Lawsuit Against Bayer Corp. for Lack of Personal Jurisdiction U.S. [read post]
12 Jan 2022, 8:38 am by Kluwer Patent blogger
“In 2012, India’s first ever compulsory license was granted by the Indian Patent Office to Natco Pharma for generic production of Bayer Corp’s Nexaver® (Sorafenib Tosylate), a life-saving medicine used for treating liver and kidney cancer. [read post]
3 Jan 2022, 12:39 pm by Kevin LaCroix
The directors’ and officers’ liability environment is always changing, but 2021 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
27 Oct 2021, 5:15 am by Dennis Crouch
Lotte International America Corp., 19-3010 (functional trade dress) Sulzer Mixpac AG v. [read post]
4 Oct 2021, 10:58 am by Rebecca Tushnet
 My presentation, galloping across a bunch of developments. [read post]
26 Oct 2020, 11:18 am by Andy Foreman
By Andy Foreman A version of this article was originally published by Law360 on Oct. 21, 2020. [read post]
14 Aug 2020, 9:02 am by Abby Meyer
Rite Aid Corp., Case No. 2:17-cv-06777 (C.D. [read post]